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ABSTRACT  
A simple, rapid, accurate and precise isocratic reversed phase high performance 
liquid chromatographic method has been developed and validated for simultaneous 
estimation of Paracetamol and Lornoxicam in tablet dosage form. The 
chromatographic separation was carried out on Zorbax C18 column (150 mm x 4.6 
mm I.D., 5 µm particle size) with a mixture of 20 mM ammonium acetate pH 3.2 buffer 
and acetonitrile in the ratio of 60:40 v/v as a mobile phase at a flow rate of 1.0 
mL/min. UV detection was performed at 265 nm. The retention times were 2.74 
minutes and 5.36 minutes for Paracetamol and Lornoxicam respectively. Calibration 
plots were linear (r2=0.999 for both Paracetamol and Lornoxicam respectively) over 
the concentration range of 6.25-250 µg/mL for Paracetamol and 0.1-4 µg/mL for 
Lornoxicam. The method was validated for linearity, precision, accuracy, ruggedness 
and robustness. The proposed method was successfully used for simultaneous 
estimation of Paracetamol and Lornoxicam in tablet dosage form. Validation studies 
revealed that the proposed method is specific, rapid, reliable and reproducible. The 
high % recovery and low % RSD confirms the suitability of the proposed method for 
routine quality control analysis of Paracetamol and Lornoxicam in bulk and tablet 
dosage form. 
INTRODUCTION
Paracetamol (Fig. 1) is a non-selective COX inhibitor 
and has weak activity on prostaglandin synthetase 
in the inflamated peripheral tissues [1]. Paracetamol 
is used to treat many conditions such as headache, 
muscle ache, arthritis, backache, toothache, cold 
and fever. Chemically it is N-acetyl-p-amino phenol 
[2].  
Lornoxicam (Fig. 2) is a potent analgesic with 
excellent anti inflammatory properties in a range of 
painful and inflammatory conditions, including 
postoperative pain and rheumatoid arthritis [3]. 
Chemically it is 6-chloro-4-hydroxy-2-methyl-N-2-
pyridinyl-2H-thieno[2,3-e]-1,2-thiazine-3-
carboxamide1,1-ioxide [4].  
Literature survey reveals that few analytical 
methods using spectrophotometry [5--7], HPLC [8-10] 
and HPTLC [11-13] have been reported for the 
simultaneous determination of Paracetamol and 
Lornoxicam in combined dosage forms. Therefore, 
an attempt has been made to develop a novel, rapid, 
accurate and precise RP-HPLC method for 
simultaneous estimation of Paracetamol and 
Lornoxicam in tablet dosage form and validated in 
accordance with ICH guidelines [14]. 
MATERIALS AND METHODS 
Instrumentation 
To develop a high performance liquid 
chromatographic method for simultaneous 
estimation of Paracetamol and Lornoxicam using 
Waters 2695 HPLC system on a Zorbax C-18 (150 
mm × 4.6 mm I.D., 5 μm particle size) column was 
used. The instrument is equipped with pump-515, 
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auto sampler-2707 and UV detector-2998. A 20 μL 
rheodyne injector port was used for injecting the 
samples. Data was analyzed by using Empower 2 
software. A Shimadzu balance was used for 
weighing the materials and Systronics-361 pH 
meter was used for pH measurements. 
Chemicals and solvents  
The reference samples of Paracetamol and 
Lornoxicam were provided as gift samples from 
Spectrum Pharma Research Solutions, Hyderabad, 
India. The marketed formulation of Paracetamol 
and Lornoxicam tablets (Paracetamol 500 mg and 
Lornoxicam 8 mg) were purchased from local 
market. HPLC grade water and acetonitrile were 
purchased from E.Merck (India) Ltd., Mumbai, 
India. Ammonium acetate and acetic acid of AR 
grade was obtained from S.D. Fine Chemicals Ltd., 
Mumbai, India.  
Chromatographic conditions  
20 mM ammonium acetate pH 3.2 buffer and 
acetonitrile in the ratio of 60:40 v/v was found to 
be the most suitable mobile phase for ideal 
chromatographic separation for simultaneous 
estimation of Paracetamol and Lornoxicam. The 
solvent mixture was filtered through 0.45 μm 
membrane filter and sonicated before use. It was 
pumped through the column at a flow rate of 1.0 
mL/min. Injection volume was 20 µL and the 
column was maintained at ambient temperature. 
The column was equilibrated by pumping the 
mobile phase through the column for at least 30 
minutes prior to the injection of the drug solution. 
The detection of the drug was monitored at 265 nm. 
The run time was set as 8 minutes. 
Preparation of mobile phase and diluent  
The mobile phase was prepared by mixing 600 mL 
of 20 mM ammonium acetate buffer (pH was 
adjusted to 3.2 with acetic acid) with 400 mL of 
acetonitrile. The solution was degassed in an 
ultrasonic water bath for 5 minutes and filtered 
through 0.45 µm filter under vacuum. The solution 
of mobile phase was used as diluent. 
Preparation of standard solution 
Accurately weighed and transferred 62.5 mg of 
Paracetamol and 1 mg of Lornoxicam working 
standards into a 100 mL clean dry volumetric flask, 
about 10 mL of diluent was added and made 
volume upto the mark with the diluent. Then it was 
filtered through 0.45 μm filter. Further 1 mL from 
above stock solution was transferred into 100 mL 
volumetric flask and diluted upto the mark with 
diluent. From this serial dilutions were prepared for 
construct the calibration curve. 
 
Preparation of sample solution  
Twenty commercial tablets were weighed and 
finely powdered. An accurately weighed portion of 
powder equivalent to 500 mg of Paracetamol and 8 
mg of Lornoxicam were transferred into a 100 mL 
volumetric flask, to this add 50 mL of diluent. The 
content of flask were sonicated for 20 min, then 
solution was filtered through a 0.45 μm membrane 
filter and then final volume of the solution was 
made upto 100 mL with diluent. Further 1 mL from 
the above stock solution was pipetted into 100 mL 
volumetric flask to get the concentration containing 
50 μg/mL of Paracetamol and 0.8 μg/mL of 
Lornoxicam.  
Procedure  
The column was maintained at ambient 
temperature. The run time was set at 8 minutes. 
The column was equilibrated by pumping the 
mobile phase through the column for at least 30 
minutes prior to the injection of the drug solutions. 
Inject 20 μL of the standard and sample solutions 
six times into the chromatographic system at a flow 
rate of 1.0 mL/min and the corresponding 
chromatograms were obtained. From these 
chromatograms, the average area under the peak of 
each dilution was computed. 
METHOD VALIDATION 
Linearity 
Several aliquots of standard solutions of 
Paracetamol and Lornoxicam were taken in seven 
different 10 mL volumetric flasks and diluted up to 
the mark with diluent such that the final 
concentrations were in the range of 6.25-250 
µg/mL for Paracetamol and 0.1-4 µg/mL for 
Lornoxicam. The above solutions were injected into 
the HPLC system keeping the injection volume 
constant. The drugs were eluted with UV detector at 
265 nm, peak areas was recorded for all the peaks. 
The linearity curves were constructed by plotting 
concentration of the drugs against peak areas. The 
regressions of the plots were computed by least 
square regression method.  
Precision 
Precision for Paracetamol and Lornoxicam was 
determined in terms of system precision and 
method precision. Every sample was injected six 
times. The measurements for peak areas were 
expressed in terms of % RSD. 
Accuracy  
The accuracy of the method was assessed by 
recovery studies of Paracetamol and Lornoxicam at 
three concentration levels 50%, 100% and 150%. 
Fixed amount of pre-analyzed sample was spiked 
with known amount of Paracetamol and 
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Lornoxicam. Each level was repeated three times. 
The % recovery of Paracetamol and Lornoxicam 
were calculated.  
System suitability  
The system suitability parameters like retention 
time, theoretical plates and tailing factor were 
evaluated by six replicate analysis of Paracetamol 
and Lornoxicam and compared with standard 
values. The acceptance criteria are % RSD of peak 
areas not more than 2%, theoretical plates numbers 
(N) at least 2000 per each peak and tailing factors 
not more than 2.0 for Paracetamol and Lornoxicam. 
Limit of detection and limit of quantification  
The limit of detection (LOD) and limit of 
quantification (LOQ) of the developed method were 
determined by injecting progressively low 
concentrations of the standard solutions of 
Paracetamol and Lornoxicam using the developed 
HPLC method. LOD and LOQ were estimated from 
signal-to-noise ratio. LOD and LOQ were calculated 
using 3.3 σ/s and 10 σ/s formulae, respectively. 
Where, σ is the standard deviation of the peak areas 
and S is the slope of the corresponding calibration 
curve. 
Robustness  
The robustness of the method was determined by 
making small deliberate changes in method like 
variation of flow rate, mobile phase ratio and 
temperature.  
Assay  
Standard preparations are made from the bulk drug 
and sample preparations are made from 
formulation. Both standard and sample solutions 
were injected in six homogeneous samples. 20 µL of 
sample solution was injected and from the peak 
areas of Paracetamol and Lornoxicam, amount of 
each drug in the sample were computed. The results 
were compared with the label claim of Paracetamol 
and Lornoxicam in tablet dosage form. From the 
results the average % Assay was calculated. 
RESULTS AND DISCUSSION  
   
Fig. 1: Chemical structure of Paracetamol   Fig. 2: Chemical structure of Lornoxicam 
 
Fig. 3: Calibration curve of Paracetamol 
y = 40828x - 23548
R² = 0.999
0
2000000
4000000
6000000
8000000
10000000
12000000
0 50 100 150 200 250 300
P
ea
k
 a
re
a
Concentration (μg/mL)
Linearity curve of Paracetmol
Series1
Linear (Series1)
IJRAPS, 2018:2(8):275-281 
 Website: http://ijraps.in  278 
 
Fig. 4: Calibration curve of Lornoxicam  
 
Fig. 5: Typical chromatogram of standard for Paracetamol and Lornoxicam 
Table 1: Optimized chromatographic conditions  
S. No. Parameter Condition 
1 Mobile phase 20 mM ammonium acetate:acetonitrile (60:40 v/v) 
2 Diluent 20 mM ammonium acetate:acetonitrile (60:40 v/v) 
3 Column Zorbax C18 (150 mm x 4.6 mm, 5 µm) 
4 Column temperature Ambient 
5 Wave length 265 nm 
6 Injection volume 20 µL 
7 Flow rate 1.0 mL/min. 
8 Run time 8 min. 
Table 2: Linearity results of Paracetamol 
S. No. Concentration (μg/mL) Mean peak area 
1 6.25 241716 
2 12.5 497904 
3 25 1010279 
4 50 2035029 
5 62.5 2447404 
6 125 5109279 
7 250 10183438 
y = 21731x + 2040.
R² = 0.999
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Table 3: Linearity results of Lornoxicam 
S. No. Concentration (μg/mL) Mean peak area 
1 0.1 3988 
2 0.2 6250 
3 0.4 9775 
4 0.8 19824 
5 1 23989 
6 2 46962 
7 4 88208 
Table 4: Precision data of Paracetamol 
S. No. 
 
Peak area 
System precision Method precision 
% RSD 0.29 0.44 
Table 5: Precision data of Lornoxicam 
S. No. 
 
Peak area 
System precision Method precision 
% RSD 0.28 0.28 
Table 6: Accuracy studies of Paracetamol 
% Concentration 
level 
Conc. 
added (μg) 
Conc. 
found (μg) 
% 
Recovery 
% Mean 
recovery 
50% 25 24.65 98.60  
99.28 100% 50 49.82 99.70 
150% 75 74.66 99.54 
Table 7: Accuracy studies of Lornoxicam 
% Concentration 
level 
Conc. 
added (μg) 
Conc. 
found (μg) 
% 
Recovery 
% Mean 
recovery 
50% 0.4 0.39 97.50  
98.47 100% 0.8 0.79 98.75 
150% 1.2 1.19 99.16 
Table 8: System suitability parameters of proposed method 
S. No. Parameters Paracetamol Lornoxicam 
1 Linearity (µg/mL) 6.25-250  0.1- 4 
2 Correlation coefficient 0.999 0.999 
3 Retention time (min.) 2.74 5.36 
4 Tailing factor 0.85 0.95 
5 Theoretical plates (N) 7445 5350 
6 LOD (µg/mL) 0.10 0.05 
7 LOQ (µg/mL) 0.30 0.15 
Table 9: Assay results of marketed formulations 
S. No. % Assay of Paracetamol 
% Assay of 
Lornoxicam 
1 99.65 99.21 
2 99.23 99.86 
3 99.4 99.74 
4 99.12 99.69 
5 99.54 99.54 
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6 99.12 99.12 
Mean 99.3 99.5 
% RSD 0.21 0.29 
The HPLC procedure was optimized with a 
view to develop an accurate, precise and 
reproducible method for simultaneous estimation 
of Paracetamol and Lornoxicam in tablet dosage 
form using Zorbax C-18 (150 mm × 4.6 mm, 5 μm) 
in isocratic mode with mobile phase composition of 
20 mM ammonium acetate and acetonitrile in the 
ratio of 60:40 v/v resulted in peak with maximum 
separation, good shape and resolution. Flow rates 
between 0.8 to 1.2 mL/min were studied. A flow 
rate of 1.0 mL/min gave an optimum signal-to-noise 
ratio with reasonable separation time, the retention 
times for Paracetamol and Lornoxicam were found 
to be 2.74 minutes and 5.36 minutes respectively. 
Total run time was 8 minutes. The drug 
components were measured with UV detector at 
265 nm. The results of optimized chromatographic 
conditions were shown in Table 1.  
Linearity was obtained in the range of 6.25-250 
µg/mL for Paracetamol and 0.1-4 µg/mL for 
Lornoxicam. The correlation coefficient (r2) was 
found to be 0.999 for both Paracetamol and 
Lornoxicam respectively. The regression equation 
of the linearity plot of concentration of Paracetamol 
over its peak area was found to be 
y=40828x+23548, where x is the concentration of 
Paracetamol (μg/mL) and y is the corresponding 
peak area. The regression equation of the linearity 
plot of concentration of Lornoxicam over its peak 
area was found to be y=21731x+2040, where x is 
the concentration of Lornoxicam (μg/mL) and y is 
the corresponding peak area. The results show that 
an excellent correlation exists between peak area 
and concentration of drugs within the 
concentration range indicated. The linearity results 
were shown in Table 2 and Table 3 and the 
calibration curves were shown in Fig. 3 and Fig. 4.  
The % RSD for system precision and method 
precision for Paracetamol were found to be 0.29% 
and 0.44% respectively (limit % RSD<2.0%). The % 
RSD for system precision and method precision for 
Lornoxicam were found to be 0.28% and 0.28% 
respectively (limit % RSD<2.0%) and hence the 
method is precise. The precision data of 
Paracetamol and Lornoxicam were furnished in 
Table 4 and Table 5.  
The % mean recovery of the drugs Paracetamol and 
Lornoxicam were found to be 99.28% and 98.47% 
respectively and the high percentage of recovery of 
Paracetamol and Lornoxicam indicates that the 
proposed method is highly accurate. The results of 
accuracy studies of Paracetamol and Lornoxicam 
were shown in Table 6 and Table 7. 
The number of theoretical plates calculated for 
Paracetamol and Lornoxicam was 7445 and 5350 
respectively. The tailing factor for Paracetamol and 
Lornoxicam was 0.85 and 0.95 respectively, which 
indicates efficient performance of the column. The 
limit of detection (LOD) and limit of quantification 
(LOQ) for Paracetamol were found to be 0.10 
µg/mL and 0.30 µg/mL; 0.05 µg/mL and 0.15 
µg/mL for Lornoxicam respectively, which indicate 
the sensitivity of the method. The summary of 
system suitability parameters and validation 
parameters were shown in Table 8.  
The robustness studies indicated that no 
considerable effect on the determination of the 
drugs. Therefore the test method is robust for the 
quantification of the drugs. In all deliberately varied 
conditions, the % RSD for replicate injections of 
Paracetamol and Lornoxicam were found to be 
within the acceptable limits.  
Validated method was applied for the simultaneous 
estimation of Paracetamol and Lornoxicam in 
commercial tablet dosage form. The % Assay of 
Paracetamol and Lornoxicam were found to be 
99.30% and 99.50% respectively. The results for 
the drugs assay showed good agreement with label 
claims. No interfering peaks were found in the 
chromatogram of the tablet formulation within the 
run time indicating that excipients used in tablet 
formulation did not interfere with the simultaneous 
estimation of the drugs Paracetamol and 
Lornoxicam by the proposed HPLC method. The 
assay results are shown in Table 9.  
The chromatograms were checked for appearance 
of any extra peaks under optimized conditions, 
showing no interference from common tablet 
excipients and impurities. Also the peak areas were 
compared with standard and were found to be 
within limits. As shown in chromatogram, two 
analytes are eluted by forming symmetrical peaks. 
The typical chromatogram of Paracetamol and 
Lornoxicam standard were shown in Fig. 5. 
CONCLUSION 
The proposed HPLC method is rapid, sensitive, 
precise and accurate for the simultaneous 
estimation of Paracetamol and Lornoxicam and can 
be reliably adopted for routine quality control 
analysis of Paracetamol and Lornoxicam in bulk and 
its tablet dosage form. 
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